Microalbuminuria and Risk for Cardiovascular Disease
Top Cited Papers
- 1 August 2006
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (8) , 2106-2111
- https://doi.org/10.1681/asn.2005121288
Abstract
Microalbuminuria is a strong and independent indicator of increased cardiovascular risk among individuals with and without diabetes. Therefore, microalbuminuria can be used for stratification of risk for cardiovascular disease. Once microalbuminuria is present, cardiovascular risk factor reduction should be more “aggressive.” The nature of the link between microalbuminuria and cardiovascular risk, however, remains poorly understood. There is no strong evidence that microalbuminuria causes atherothrombosis or that atherothrombosis causes microalbuminuria. Many studies have tested the hypothesis that a common risk factor underlies the association between microalbuminuria and cardiovascular disease but, again, have found no strong evidence in favor of this contention. At present, the most likely possibility is that a common pathophysiologic process, such as endothelial dysfunction, chronic low-grade inflammation, or increased transvascular leakage of macromolecules, underlies the association between microalbuminuria and cardiovascular disease, but more and prospective studies of these hypotheses are needed.Keywords
This publication has 36 references indexed in Scilit:
- The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health StudyAtherosclerosis, 2005
- Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive PatientsHypertension, 2005
- Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn StudyKidney International, 2004
- Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudyJournal Of Hypertension, 2004
- Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is notAtherosclerosis, 2004
- Endothelial Function and DysfunctionPublished by Wiley ,2003
- Is it time to measure microalbuminuria in hypertension?Journal Of Hypertension, 2003
- Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn StudyKidney International, 2002
- Rapid Progression of Albumin Excretion Is an Independent Predictor of Cardiovascular Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaDiabetes Care, 2001
- Predictors of Cardiovascular Morbidity in Treated Hypertension: Results from the Primary Preventive Trial in Goteborg, SwedenJournal Of Hypertension, 1985